SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare negotiating with various parties for utilising spare capacity

22 Jan 2020 Evaluate

Themis Medicare is presently negotiating with various parties for utilising spare capacity for carrying out contract manufacturing of finished products, and if negotiations are successful, the company will enter into contracts with such parties.

Further, pursuant to notification issued by Ministry of Road Transport and Highways, Government of India, making it mandatory to include Feracrylum 1% Gel 15gms in first aid kit for all types of vehicles coming out from the Auto Manufacturers, the company has started receiving orders for supply of Feracrylum 1% Gel 15gms to be included in first aid kit and is likely to receive similar such orders in future.

Themis Medicare (TML) is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations.

Themis Medicare Share Price

90.99 0.74 (0.82%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×